...
首页> 外文期刊>Nature reviews Cancer >Proliferation of human hepatocellular carcinoma cells from surgically resected specimens under conditionally reprogrammed culture
【24h】

Proliferation of human hepatocellular carcinoma cells from surgically resected specimens under conditionally reprogrammed culture

机译:在条件重新编程培养下,手术切除标本的人肝细胞癌细胞的激增

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Hepatocellular carcinoma (HCC) is the third most common cause of cancer mortality worldwide, which is partially due to the lack of appropriate therapeutic options. The development of HCC is accompanied with unique and continuous genomic and epigenetic modifications. Therefore, the absence of a personalized and reproducible human model reduces the ability to determine the potential of candidate treatments. Conditional reprogramming (CR) culture has been used to establish and indefinitely grow patient-derived tumor cell lines in a rapid and efficient manner. In the present study, primary HCC cells were isolated from tumor specimens and cultured under CR conditions. The proliferative potential and capacity of cells to undergo continuous regeneration were evaluated by cell viability and proliferation assays, and the expression of tumor-specific markers was determined by western blotting and immunofluorescence to determine the prospects for use in clinical settings. It was demonstrated that similar to 55% of tumor samples were able to generate HCC cells that could be continuously expanded and passaged under CR conditions; this ability was associated with the source and composition of the tumor tissues. Furthermore, the expression of the tumor-specific marker alpha-fetoprotein and the proliferative ability of cells were maintained following cycles of cryopreservation and resuscitation. In conclusion, with further optimization, the CR system may be a useful tool for the precise therapeutic treatment of patients with HCC.
机译:肝细胞癌(HCC)是全世界癌症死亡率最常见的最常见原因,部分是由于缺乏适当的治疗选择。 HCC的发展伴随着独特和连续的基因组和表观遗传修饰。因此,没有个性化和可重复的人体模型降低了确定候选治疗潜力的能力。条件重编程(Cr)培养已被用于以快速有效的方式建立和无限期地生长患者衍生的肿瘤细胞系。在本研究中,原发性HCC细胞与肿瘤标本分离并在Cr条件下培养。通过细胞活力和增殖测定评估细胞的增殖潜力和能力进行连续再生,并通过蛋白质印迹和免疫荧光测定肿瘤特异性标记物,以确定临床环境中使用的前景。结果表明,类似于55%的肿瘤样品能够产生可以在Cr条件下连续扩增和传代的HCC细胞;这种能力与肿瘤组织的来源和组成相关。此外,在冷冻保存和复苏的循环后,将肿瘤特异性标记α-胎儿蛋白和细胞增殖能力的表达进行。总之,随着进一步优化,CR系统可以是HCC患者精确治疗的有用工具。

著录项

  • 来源
    《Nature reviews Cancer》 |2019年第6期|共8页
  • 作者单位

    Tianjin First Ctr Hosp Pathol Dept Tianjin 300192 Peoples R China;

    Tianjin First Ctr Hosp Biol Sample Resource Sharing Ctr Tianjin 300192 Peoples R China;

    Tianjin First Ctr Hosp Organ Transplantat Dept 24 Fukang Rd Tianjin 300192 Peoples R China;

    Chinese Acad Med Sci Minist Hlth Key Lab Crit Care Med Tianjin 300192 Peoples R China;

    Chinese Acad Med Sci Key Lab Transplant Med Tianjin 300192 Peoples R China;

    Tianjin Key Lab Organ Transplantat Tianjin 300192 Peoples R China;

    Tianjin First Ctr Hosp Organ Transplantat Dept 24 Fukang Rd Tianjin 300192 Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 肿瘤学;
  • 关键词

    HCC; conditional reprogramming; tumor specimens; precision therapy;

    机译:HCC;条件重新编程;肿瘤标本;精确治疗;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号